OpenAlex
PricingAboutJobs
Log inGet started
Work

Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule

HTML

Year: 2007
Type: article
Source: Cancer Research
DOI: 10.1158/0008-5472.can-06-1630
Authors: Vladimir Tolmachev, Anna Orlova, Rikard Pehrson, Joakim Galli, Barbro Baastrup, Karl Andersson, Mattias Sandström, Daniel Rosik, Jörgen Carlsson, Hans Lundqvist, Anders Wennborg, Fredrik Y. Nilsson
Institutions: Uppsala University, Uppsala University Hospital, Affibody (Sweden), University of Alabama at Birmingham
Language: English

Topic: Radiopharmaceutical Chemistry and Applications
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Keywords: HER2-positive cancer, radionuclide therapy, lutetium-177, Affibody molecules, albumin-binding domain, tissue distribution, targeted therapy, DTPA, HER2 imaging
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1985312565
FWCI: 14.43
Cites: 49
Cited by: 234
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms